HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David G Hicks Selected Research

Keratins (Keratin)

10/2010Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.
10/2009Malignant solitary fibrous tumor: report of 3 cases with unusual features.
9/2006Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David G Hicks Research Topics

Disease

62Breast Neoplasms (Breast Cancer)
03/2024 - 01/2005
49Neoplasms (Cancer)
01/2024 - 10/2002
8Carcinoma (Carcinomatosis)
03/2024 - 07/2006
7Neoplasm Metastasis (Metastasis)
01/2020 - 01/2005
6Adenocarcinoma
03/2024 - 04/2005
4Carcinogenesis
01/2015 - 01/2009
3Pathologic Complete Response
01/2022 - 06/2008
3Lobular Carcinoma
01/2020 - 10/2010
2Ductal Carcinoma
01/2016 - 09/2014
2Urinary Bladder Neoplasms (Bladder Cancer)
11/2012 - 01/2009
2Disease Progression
01/2012 - 01/2005
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024
1Residual Neoplasm
12/2023
1Endometrial Neoplasms (Endometrial Cancer)
10/2023
1Adenocarcinoma of Lung
06/2023
1Genomic Instability
10/2017
1Triple Negative Breast Neoplasms
07/2014
1Hypoxia (Hypoxemia)
12/2012
1Arthritis (Polyarthritis)
01/2012
1Stomach Neoplasms (Stomach Cancer)
12/2011
1Hypoglycemia (Reactive Hypoglycemia)
10/2009
1Glioblastoma (Glioblastoma Multiforme)
10/2007
1Giant Cell Tumors (Giant Cell Tumor)
06/2007
1Cherubism
06/2007

Drug/Important Bio-Agent (IBA)

20Estrogen ReceptorsIBA
01/2022 - 07/2006
18Proteins (Proteins, Gene)FDA Link
04/2023 - 01/2005
14Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2006
14human ERBB2 proteinIBA
04/2023 - 09/2006
13Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 11/2006
10Hormones (Hormone)IBA
12/2023 - 01/2005
8Trastuzumab (Herceptin)FDA Link
12/2018 - 03/2005
7Phenobarbital (Luminal)FDA Link
01/2022 - 06/2009
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 09/2006
4Epidermal Growth Factor (EGF)IBA
12/2023 - 04/2005
4Monoclonal AntibodiesIBA
01/2023 - 12/2004
4Estrogens (Estrogen)FDA Link
01/2021 - 01/2010
4Coloring Agents (Dyes)IBA
10/2017 - 07/2006
4ParaffinIBA
03/2015 - 12/2004
3trastuzumab deruxtecanIBA
12/2023 - 09/2022
3Messenger RNA (mRNA)IBA
12/2023 - 03/2005
3Immunoconjugates (Immunoconjugate)IBA
10/2023 - 03/2022
3AntibodiesIBA
06/2023 - 07/2006
3Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 10/2002
3Indicators and Reagents (Reagents)IBA
01/2016 - 07/2006
3Formaldehyde (Formol)FDA Link
03/2015 - 05/2010
3Carrier Proteins (Binding Protein)IBA
01/2015 - 06/2007
3Androgen Receptors (Androgen Receptor)IBA
08/2014 - 06/2009
3Keratins (Keratin)IBA
10/2010 - 09/2006
2Vitamin EFDA LinkGeneric
01/2015 - 06/2009
2Small Interfering RNA (siRNA)IBA
06/2007 - 03/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2024
1Nucleic AcidsIBA
01/2024
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
01/2023
1abemaciclibIBA
01/2023
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2021
1StreptavidinIBA
12/2018
1Carcinoembryonic AntigenIBA
08/2015
1AntigensIBA
08/2015
1PhosphoproteinsIBA
03/2015
1Tocopherols (Tocopherol)IBA
01/2015
1CateninsIBA
09/2014
1Cadherins (E-Cadherin)IBA
09/2014
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2014
1SteroidsIBA
01/2014
1LignansIBA
01/2014
1Aromatase InhibitorsIBA
01/2014
1Anastrozole (Arimidex)FDA LinkGeneric
01/2014
1Lysine (L-Lysine)FDA Link
12/2012
1Transcription Factors (Transcription Factor)IBA
11/2012
1Tyrosine (L-Tyrosine)FDA Link
01/2012
1AndrogensIBA
01/2012
1HSP27 Heat-Shock ProteinsIBA
01/2011
14-trimethylamino-1-butanol (HBTM)IBA
01/2011
1Insulin-Like Growth Factor II (Somatomedin A)IBA
10/2009
1TamoxifenFDA LinkGeneric
07/2009
1alpha-TocopherolFDA Link
06/2009
1Taxoids (Taxanes)IBA
01/2009
1Plasminogen Activator Inhibitor 1IBA
01/2009
1Plasminogen InactivatorsIBA
01/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2008
1OligonucleotidesIBA
10/2007
1NFATC Transcription FactorsIBA
06/2007
1matrigelIBA
06/2007
1p38 Mitogen-Activated Protein KinasesIBA
06/2007
1PaxillinIBA
03/2007
1Proto-Oncogene Proteins c-etsIBA
03/2007
1SurvivinIBA
03/2007
1SilverIBA
03/2007
1LuciferasesIBA
03/2007

Therapy/Procedure

24Therapeutics
10/2023 - 03/2005
8Drug Therapy (Chemotherapy)
01/2023 - 01/2003
4Neoadjuvant Therapy
12/2023 - 01/2019
2Adjuvant Chemotherapy
12/2016 - 03/2010
1Precision Medicine
11/2019
1Mammaplasty (Breast Reconstruction)
01/2016
1Cystectomy
11/2012
1Mastectomy (Mammectomy)
04/2012
1Inappropriate Prescribing
08/2009
1Intravesical Administration
01/2009
1Aftercare (After-Treatment)
12/2008